New insights into Parkinson's disease

Super-resolution microscopy tech was used to track the tipping point in Parkinson's disease; the change in chemistry in the brain that triggers the disease. And the researchers at the University of Cambridge concluded that the same protein evidently can either protect or spur the toxic effects in the brain that kills brain cells, depending on the form it takes. Release

Suggested Articles

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.